Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'REMISSION INDUCTION' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 164 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Buchner, T; Hiddemann, W; Schoch, C; Haferlach, T; Sauerland, MC; Heinecke, A
      Acute myeloid leukaemia (AML): treatment of the older patient

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    2. Fenaux, P; Chomienne, C; Degos, L
      Treatment of acute promyelocytic leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    3. Estey, EH
      Growth factors in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    4. Holdsworth, MT; Mathew, P
      Efficacy of colony-stimulating factors in acute leukemia

      ANNALS OF PHARMACOTHERAPY
    5. Rex, JH; Sobel, JD
      Prophylactic antifungal therapy in the intensive care unit

      CLINICAL INFECTIOUS DISEASES
    6. Nguyen, Q; Estey, E; Raad, I; Rolston, K; Kantarjian, H; Jacobson, K; Konoplev, S; Ghosh, S; Luna, M; Tarrand, J; Whimbey, E
      Cytomegalovirus pneumonia in adults with leukemia: An emerging problem

      CLINICAL INFECTIOUS DISEASES
    7. Cataland, SR; Daugherty, CK; Weseman, EC; Larson, RA
      Preliminary experience with a new chemotherapy regimen for adults with acute lymphoblastic leukemia

      LEUKEMIA & LYMPHOMA
    8. Preisler, HD; Venugopal, P; Gregory, SA; Adler, S; Gezer, S; Hsu, WT; Manson, S; Larson, A; Jajeh, A; Slvinick, D; Galvez, A
      High remission rate in acute myeloblastic leukemia with only two days of chemotherapy

      LEUKEMIA & LYMPHOMA
    9. Khorana, A; Bunn, P; McLaughlin, P; Vose, J; Stewart, C; Czuczman, MS
      A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma

      LEUKEMIA & LYMPHOMA
    10. Verma, A; Stock, W
      Management of adult acute lymphoblastic leukemia: moving toward a risk-adapted approach

      CURRENT OPINION IN ONCOLOGY
    11. Pinto, A; Zagonel, V; Ferrara, F
      Acute myeloid leukemia in the elderly: biology and therapeutic strategies

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    12. Wingard, JR; Leather, HL
      Empiric antifungal therapy for the neutropenic patient

      ONCOLOGY-NEW YORK
    13. Weiss, M
      Induction therapy of adult acute lymphocytic leukemia without the use of vincristine or prednisone

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    14. Kantarjian, HM
      Adult acute lymphocytic leukemia - Future research directions

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    15. Ahlmann, M; Lanvers, C; Lumkemann, K; Rossig, C; Freund, A; Baumann, M; Boos, J
      Modulation of ara-CTP levels by fludarabine and hydroxyurea in leukemic cells

      LEUKEMIA
    16. Clavio, M; Quintino, S; Masoudi, B; Carrara, S; Cerri, R; Pierri, I; Canepa, L; Miglino, M; Muner, P; Damasio, E; Gobbi, M
      Cost of de novo acute myeloid leukemia induction therapy in adults: Analysis of EORTC-GIMEMA AML10 and FLANG regimens

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    17. Tallman, MS
      Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies

      BLOOD REVIEWS
    18. Lopez, A; de la Rubia, J; Martin, G; Martinez, J; Cervera, J; Jarque, I; Sempere, A; Plume, G; Saavedra, S; Regadera, A; Sanz, G; Gomis, F; Perez-Sirvent, ML; Senent, L; Jimenez, C; Sanz, MA
      Recent improvements in outcome for elderly patients with de novo acute myeloblastic leukemia

      LEUKEMIA RESEARCH
    19. Rios, JA; Korones, DN; Heal, JM; Blumberg, N
      WBC-reduced blood transfusions and clinical outcome in children with acutelymphoid leukemia

      TRANSFUSION
    20. Estey, E
      Reducing mortality associated with immediate treatment complications of adult leukemias

      SEMINARS IN HEMATOLOGY
    21. Kantarjian, HM; Talpaz, M; Santini, V; Murgo, A; Cheson, B; O'Brien, SM
      Homoharringtonine - History, current research, and future directions

      CANCER
    22. Thomas, X; Berhabri, A
      Acute myeloid leukemia in the elderly: a review

      BULLETIN DU CANCER
    23. Goldstone, AH; Burnett, AK; Wheatley, K; Smith, AG; Hutchinson, RM; Clark, RE
      Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial

      BLOOD
    24. Stone, RM; Berg, DT; George, SL; Dodge, RK; Paciucci, PA; Schulman, PP; Lee, EJ; Moore, JO; Powell, BL; Baer, MR; Bloomfield, CD; Schiffer, CA
      Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine

      BLOOD
    25. Sijmons, EA; Heintz, PM
      Second-look and second surgery: Second chance or second best?

      SEMINARS IN SURGICAL ONCOLOGY
    26. Hicsonmez, G
      A novel approach to treatment with high-dose steroid as a differentiation inducer in children with acute myeloblastic leukemia

      PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE
    27. Tiraboschi, IN; Bennett, JE; Kauffman, CA; Rex, JH; Girmenia, C; Sobel, JD; Menichetti, F
      Deep Candida infections in the neutropenic and non-neutropenic host: an ISHAM symposium

      MEDICAL MYCOLOGY
    28. Knox, JJ; Puodziunas, ALV; Feld, R
      Chemotherapy-induced oral mucositis - Prevention and management

      DRUGS & AGING
    29. Williams, JP; Handler, HL
      Antibody-targeted chemotherapy for the treatment of relapsed acute myeloidleukemia

      AMERICAN JOURNAL OF MANAGED CARE
    30. Latagliata, R; Breccia, M; Pulsoni, A; Spiriti, MAL; D'Elia, GM; Spadea, A; Montefusco, E; Luzi, G; Betro, P; Petti, MC
      Acute myeloblastic leukemia secondary to myelodysplasia (MDS-AML): a comparison of remission induction with three drugs versus standard two-drugs induction

      LEUKEMIA & LYMPHOMA
    31. Thiebaut, A; Thomas, X; Belhabri, A; Anglaret, B; Archimbaud, E
      Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis

      ANNALS OF HEMATOLOGY
    32. Takeshita, A; Saito, H; Toyama, K; Horiuchi, A; Kuriya, S; Furusawa, S; Tsuruoka, N; Takiguchi, T; Matsuda, T; Utsumi, M; Shiku, H; Matsui, T; Egami, K; Tamura, K; Ohno, R
      Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    33. Finiewicz, K; Wingard, JR
      Management of infections in patients with acute leukemia - The article reviewed

      ONCOLOGY-NEW YORK
    34. Kantarjian, HM
      Adult acute lymphocytic leukemia - Introduction and questions related to current programs

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    35. Larson, RA
      Recent clinical trials in acute lymphocytic leukemia by the Cancer and Leukemia Group B

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    36. Lancet, JE; Willman, CL; Bennett, JM
      Acute myelogenous leukemia and aging - Clinical interactions

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    37. Rowe, JM
      Treatment of acute myelogenous leukemia in older adults

      LEUKEMIA
    38. Laverdiere, M; Rotstein, C; Bow, EJ; Roberts, RS; Ioannou, S; Carr, D; Moghaddam, N
      Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients

      Journal of antimicrobial chemotherapy
    39. Owen, RG; Johnson, SA; Morgan, GJ
      Waldenstrom's macroglobulinaemia: Laboratory diagnosis and treatment

      HEMATOLOGICAL ONCOLOGY
    40. Blijlevens, NMA; Donnelly, JP; De Pauw, BE
      Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview

      BONE MARROW TRANSPLANTATION
    41. Fuskevag, OM; Kristiansen, C; Olsen, R; Aarbakke, J; Lindal, S
      Microvascular perturbations in rats receiving the maximum tolerated dose of methotrexate or its major metabolite 7-hydroxymethotrexate

      ULTRASTRUCTURAL PATHOLOGY
    42. Li, BR; Yang, J; Tao, M; Nayini, J; Horvath, E; Chopra, H; Meyer, PM; Venugopal, P; Preisler, HD
      Poor prognosis acute myelogenous leukemia 2 - biological and molecular biological characteristics and treatment outcome

      LEUKEMIA RESEARCH
    43. Preisler, HD; Venugopal, P; Gregory, SA; Hsu, WT; Loew, J; Adler, S; Gezer, S; Creech, S; Galvez, A; Slivnick, D; Andric, T; Larson, RA; Jajeh, A
      Poor prognosis acute myelogenous leukemia: 1 - response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine)

      LEUKEMIA RESEARCH
    44. Lemez, P; Galikova, J; Haas, T
      Do de nova acute myeloid leukemias with normal cytogenetics involve two main prognostic categories distinguished by the presence of erythroblastic and/or megakaryocytic dysplasia?

      NEOPLASMA
    45. Karthaus, M; Doellmann, T; Klimasch, T; Elser, C; Rosenthal, C; Ganser, A; Heil, G
      Intensive intravenous amphotericin B for prophylaxis of systemic fungal infections - Results of a prospective controlled pilot study in acute leukemia patients

      CHEMOTHERAPY
    46. Kanda, Y; Yamamoto, R; Chizuka, A; Hamaki, T; Suguro, M; Arai, C; Matsuyama, T; Takezako, N; Miwa, A; Kern, W; Kami, M; Akiyama, H; Hirai, H; Togawa, A
      Prophylactic action of oral fluconazole against fungal infection in neutropenic patients - A meta-analysis of 16 randomized, controlled trials

      CANCER
    47. Hurwitz, CA; Silverman, LB; Schorin, MA; Clavell, LA; Dalton, VK; Glick, KM; Gelber, RD; Sallan, SE
      Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia

      CANCER
    48. Kanda, Y; Hamaki, T; Yamamoto, R; Chizuka, A; Suguro, M; Matsuyama, T; Takezako, N; Miwa, A; Kami, M; Hirai, H; Togawa, A
      The clinical significance of CD34 expression in response to therapy of patients with acute myeloid leukemia - An overview of 2483 patients from 22 studies

      CANCER
    49. Prentice, HG; Kibbler, CC; Prentice, AG
      Towards a targeted, risk-based, antifungal strategy in neutropenic patients

      BRITISH JOURNAL OF HAEMATOLOGY
    50. Wada, M; Mizoguchi, H; Kuriya, S; Taguchi, H; Kawamura, T; Maekawa, I; Shimazaki, C; Sato, Y; Niho, Y; Miyazaki, T; Shibata, A; Kitani, T; Hamajima, N; Ohno, R
      Induction therapy consisting of alternating cycles of ranimustine, vincristine, melphalan, dexamethasone and interferon alpha (ROAD-IN) and a randomized comparison of interferon alpha maintenance in multiple myeloma: a co-operative study in Japan

      BRITISH JOURNAL OF HAEMATOLOGY
    51. Hale, G; Waldmann, H
      From laboratory to clinic - The story of CAMPATH-1

      DIAGNOSTIC AND THERAPEUTIC ANTIBODIES
    52. Nichols, CR
      Treatment of recurrent germ cell tumors

      SEMINARS IN SURGICAL ONCOLOGY
    53. Bolam, S; Hamblin, T
      Colony-stimulating factors in the treatment of older patients with acute myelogenous leukaemia

      DRUGS & AGING
    54. Rotstein, C; Bow, EJ; Laverdiere, M; Ioannou, S; Carr, D; Moghaddam, N
      Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: Benefit based on purpose and intensity of cytotoxic therapy

      CLINICAL INFECTIOUS DISEASES
    55. Belhabri, A; Thomas, X; Troncy, J; Assouline, D; Michallet, M; Wattel, E; Tigaud, JD; Blanc, M; Fiere, D; Archimbaud, E
      Continuous-infusion carboplatin in combination with idarubicin or mitoxantrone for high-risk acute myeloid leukemia: a randomised phase II study

      LEUKEMIA & LYMPHOMA
    56. Lowenthal, RM; Bradstock, KF; Matthews, JP; Bishop, JF; Juneja, S; Cobcroft, R; Eliadis, P; Enno, A; Gill, D; Herrmann, RP; Manoharan, A; Page, FJ; Rooney, KF; Rosenfeld, D; Seldon, M; Taylor, KM; Wolf, MM; Young, GAR
      A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia

      LEUKEMIA & LYMPHOMA
    57. Mangi, MH; Newland, AC
      Febrile neutropenia: Prophylactic and therapeutic use of GM-CSF

      EUROPEAN JOURNAL OF CANCER
    58. Maertens, JA; Boogaerts, MA
      Antifungal prophylaxis in neutropenia

      CURRENT OPINION IN INFECTIOUS DISEASES
    59. Wurthner, J; Rump, LC; Grotz, W; Engelhardt, R; Lubbert, M
      Management of acute myeloid leukaemia following myelodysplastic syndrome in a kidney graft recipient

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    60. Yoshida, M; Tsubaki, K; Kobayashi, T; Tanimoto, M; Kuriyama, K; Murakami, H; Minami, S; Hiraoka, A; Takahashi, I; Naoe, T; Asou, N; Kageyama, S; Tomonaga, M; Saito, H; Ohno, R
      Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    61. Miyawaki, S; Tanimoto, M; Kobayashi, T; Minami, S; Tamura, J; Omoto, E; Kuriyama, K; Hatake, K; Saito, K; Kanamaru, A; Oh, H; Ohtake, S; Asou, N; Sakamaki, H; Yamada, O; Jinnai, I; Tsubaki, K; Takeyama, K; Hiraoka, A; Matsuda, S; Takahashi, M; Shimazaki, C; Adachi, K; Kageyama, S; Sakura, T; Ohno, R
      No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    62. Bennett, CL; Bishop, MR; Tallman, MS; Somerfield, MR; Feinglass, J; Smith, TJ
      The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: Results from the 1997 American Society of Clinical Oncology survey

      ANNALS OF ONCOLOGY
    63. Ossenkoppele, GJ; van der Holt, B; Verhoef, GEG; Daenen, SMGJ; Verdonck, LF; Sonneveld, P; Wijermans, PW; van der Lelie, J; van Putten, WLJ; Lowenberg, B
      A randomized study of granulocyte colony-stimulating factor applied duringand after chemotherapy in patients with poor risk myelodysplastic syndromes: a report from the HOVON Cooperative Group

      LEUKEMIA
    64. Thomas, X; Fenaux, P; Dombret, H; Delair, S; Dreyfus, F; Tilly, H; Vekhoff, A; Cony-Makhoul, P; Leblond, V; Troussard, X; Cordonnier, C; de Revel, T; Simon, M; Nicolini, F; Stoppa, AM; Janvier, M; Bordessoule, D; Rousselot, P; Ffrench, M; Marie, JP; Archimbaud, E
      Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)

      LEUKEMIA
    65. Archimbaud, E; Jehn, U; Thomas, X; De Cataldo, F; Fillet, G; Belhabri, A; Peaud, PY; Martin, C; Amadori, S; Willemze, R
      Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction consolidation therapy, followedby a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia

      LEUKEMIA
    66. Liang, DC; Hung, IJ; Yang, CP; Lin, KH; Chen, JS; Hsiao, TC; Chang, TT; Pui, CH; Lee, CH; Lin, KS
      Unexpected mortality from the use of E-coli L-asparaginase during remission induction therapy for childhood acute lymphoblastic leukemia: a report from the Taiwan Pediatric Oncology Group

      LEUKEMIA
    67. Lunel, FMV; Meis, JFGM; Voss, A
      Nosocomial fungal infections: Candidemia

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    68. Hiddemann, W; Kern, W; Schoch, C; Fonatsch, C; Heinecke, A; Wormann, B; Buchner, T
      Management of acute myeloid leukemia in elderly patients

      JOURNAL OF CLINICAL ONCOLOGY
    69. Picardi, M; Selleri, C; Camera, A; Catalano, L; Rotoli, B
      Early detection by ultrasound scan of severe post-chemotherapy gut complications in patients with acute leukemia

      HAEMATOLOGICA
    70. Kobayashi, T; Tobinai, K; Shimoyama, M; Mikuni, C; Konda, S; Kozuru, M; Araki, K; Sai, T; Fukuhara, S; Matsumoto, M; Aoki, I; Deura, K; Oyama, A; Hotta, T; Abe, T; Toki, H; Nagai, M; Fukuda, H; Niimi, M; Yamaguchi, N; Tajima, K; Shirakawa, S
      Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    71. Stevens, DA
      Itraconazole in cyclodextrin solution

      PHARMACOTHERAPY
    72. Johansen, HK; Gotzsche, PC
      Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    73. Dyer, MJS
      The role of CAMPATH-I antibodies in the treatment of lymphoid malignancies

      SEMINARS IN ONCOLOGY
    74. Lowenberg, B; Downing, JR; Burnett, A
      Medical progress - Acute myeloid leukemia

      NEW ENGLAND JOURNAL OF MEDICINE
    75. Gould, HJ; Mackay, GA; Karagiannis, SN; O'Toole, CM; Marsh, PJ; Daniel, BE; Coney, LR; Zurawski, VR; Joseph, M; Capron, M; Gilbert, M; Murphy, GF; Korngold, R
      Comparison of IgE and IgG antibody-dependent cytotoxicity in vitro and in a SCID mouse xenograft model of ovarian carcinoma

      EUROPEAN JOURNAL OF IMMUNOLOGY
    76. Bohme, A; Karthaus, M; Hoelzer, D
      Antifungal prophylaxis in neutropenic patients with hematologic malignancies: Is there a real benefit?

      CHEMOTHERAPY
    77. Morgenstern, GR; Prentice, AG; Prentice, HG; Ropner, JE; Schey, SA; Warnock, DW
      A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies

      BRITISH JOURNAL OF HAEMATOLOGY
    78. Wirth, K; Fetscher, S; Neumann-Haefelin, D; Herget, GW; Lubbert, M
      Lethal systemic herpes simplex virus type 1 infection during chemotherapy for acute lymphoblastic leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    79. Archimbaud, E; Ottmann, OG; Yin, JAL; Lechner, K; Dombret, H; Sanz, MA; Heil, G; Fenaux, P; Brugger, W; Barge, A; O'Brien-Ewen, C; Matcham, J; Hoelzer, D
      A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as anadjunct to chemotherapy for adults with de novo acute myeloid leukemia

      BLOOD
    80. Czuczman, MS; Dodge, RK; Stewart, CC; Frankel, SR; Davey, FR; Powell, BL; Szatrowski, TP; Schiffer, CA; Larson, RA; Bloomfield, CD
      Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8364

      BLOOD
    81. Wetzler, M; Dodge, RK; Mrozek, K; Carroll, AJ; Tantravahi, R; Block, AW; Pettenati, MJ; Le Beau, MM; Frankel, SR; Stewart, CC; Szatrowski, TP; Schiffer, CA; Larson, RA; Bloomfield, CD
      Prospective karyotype analysis in adult acute lymphoblastic leukemia: The Cancer and Leukemia Group B experience

      BLOOD
    82. Kern, W; Schoch, C; Fonatsch, C; Heinecke, A; Wormann, B; Buchner, T; Hiddemann, W
      Treatment of acute myeloid leukaemia in elderly patients

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    83. LIENARD D; EGGERMONT AM; KROON BBR; KOOPS HS; LEJEUNE FJ
      ISOLATED LIMB PERFUSION IN PRIMARY AND RECURRENT MELANOMA - INDICATIONS AND RESULTS

      Seminars in surgical oncology
    84. KOOPS HS; EGGERMONT AMM; LIENARD D; KROON BBR; HOEKSTRA HJ; VANGEEL AN; NIEWEG OE; LEJEUNE FJ
      HYPERTHERMIC ISOLATED LIMB PERFUSION FOR THE TREATMENT OF SOFT-TISSUESARCOMAS

      Seminars in surgical oncology
    85. THOMPSON JF; KAM PCA; WAUGH RC; HARMAN CR
      ISOLATED LIMB INFUSION WITH CYTOTOXIC AGENTS - A SIMPLE ALTERNATIVE TO ISOLATED LIMB PERFUSION

      Seminars in surgical oncology
    86. AIGNER KR
      INTRAARTERIAL INFUSION - OVERVIEW AND NOVEL APPROACHES

      Seminars in surgical oncology
    87. VAHRMEIJER AL; VANDEREB MM; VANDIERENDONCK JH; KUPPEN PJK; VANDEVELDE CJH
      DELIVERY OF ANTICANCER DRUGS VIA ISOLATED HEPATIC PERFUSION - A PROMISING STRATEGY IN THE TREATMENT OF IRRESECTABLE LIVER METASTASES

      Seminars in surgical oncology
    88. OFFNER F; CORDONNIER C; LJUNGMAN P; PRENTICE HG; ENGELHARD D; DEBACQUER D; MEUNIER F; DEPAUW B
      IMPACT OF PREVIOUS ASPERGILLOSIS ON THE OUTCOME OF BONE-MARROW TRANSPLANTATION

      Clinical infectious diseases
    89. OHNO R
      MULTICENTER COOPERATIVE STUDY-GROUP IN HEMATOLOGY IN JAPAN - THE 10-YEAR HISTORY AND ROLE OF THE JAPAN ADULT LEUKEMIA STUDY-GROUP IN JAPAN

      International journal of hematology
    90. ASOU N; ADACHI K; TAMURA J; KANAMARU A; KAGEYAMA S; HIRAOKA A; OMOTO E; AKIYAMA H; TSUBAKI K; SAITO K; KURIYAMA K; OH H; KITANO K; MIYAWAKI S; TAKEYAMA K; YAMADA O; NISHIKAWA K; TAKAHASHI M; MATSUDA S; OHTAKE S; SUZUSHIMA H; EMI N; OHNO R
      ANALYSIS OF PROGNOSTIC FACTORS IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTICLEUKEMIA TREATED WITH ALL-TRANS-RETINOIC ACID AND CHEMOTHERAPY

      Journal of clinical oncology
    91. OHNO R
      COOPERATIVE ONCOLOGY GROUPS IN JAPAN - EXPERIENCE FROM THE JAPAN ADULT LEUKEMIA STUDY-GROUP

      Cancer chemotherapy and pharmacology
    92. DEGROOT K; MUHLER M; REINHOLDKELLER E; PAULSEN J; GROSS WL
      INDUCTION OF REMISSION IN WEGENERS GRANULOMATOSIS WITH LOW-DOSE METHOTREXATE

      Journal of rheumatology
    93. BOW EJ
      INFECTION RISK AND CANCER-CHEMOTHERAPY - THE IMPACT OF THE CHEMOTHERAPEUTIC REGIMEN IN PATIENTS WITH LYMPHOMA AND SOLID TISSUE MALIGNANCIES

      Journal of antimicrobial chemotherapy
    94. WARNOCK DW
      FUNGAL-INFECTIONS IN NEUTROPENIA - CURRENT PROBLEMS AND CHEMOTHERAPEUTIC CONTROL

      Journal of antimicrobial chemotherapy
    95. HAROUSSEAU JL
      ACUTE MYELOID-LEUKEMIA IN THE ELDERLY

      Blood reviews
    96. Richardson, MD; Kokki, MH
      Diagnosis and prevention of fungal infection in the immunocompromised patient

      BLOOD REVIEWS
    97. HARAKATI MS; ALMOMEN AM; AJARIM DS; ALMOHARIB FI; ALTHEYAB A; FAWZY EM; ALGWAIZ L; ALKHAIRY KS
      ADULT ACUTE MYELOBLASTIC-LEUKEMIA - EXPERIENCE AT KING-KHALID-UNIVERSITY-HOSPITAL

      Annals of saudi medicine
    98. GINALDI L; DEMARTINIS M; MATUTES E; FARAHAT N; MORILLA R; DYER MJS; CATOVSKY D
      LEVELS OF EXPRESSION OF CD52 IN NORMAL AND LEUKEMIC B-CELLS AND T-CELLS - CORRELATION WITH IN-VIVO THERAPEUTIC RESPONSES TO CAMPATH-1H

      Leukemia research
    99. Chryssanthou, E; Kalin, M; Engervall, P; Petrini, B; Bjorkholm, M
      Low incidence of candidaemia among neutropenic patients treated for haematological diseases

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    100. KERN W; BEHRE G; RUDOLF T; KERKHOFF A; GROTEMETKE A; EIMERMACHER H; KUBICA U; WORMANN B; BUCHNER T; HIDDEMANN W
      FAILURE OF FLUCONAZOLE PROPHYLAXIS TO REDUCE MORTALITY OR THE REQUIREMENT OF SYSTEMIC AMPHOTERICIN-B THERAPY DURING TREATMENT FOR REFRACTORY ACUTE MYELOID-LEUKEMIA - RESULTS OF A PROSPECTIVE RANDOMIZED PHASE-III STUDY

      Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 03:28:22